Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit
NCT05282004
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Neovascular Age-related Macular Degeneration (nAMD)
Interventions
DRUG:
SOK583A1
Sponsor
Sandoz